ML
CRL icon

Mayport LLC’s Charles River Laboratories CRL Stock Holding History

Mayport LLC’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-635
Closed -$239K – 62
2021
Q4 		$239K Buy
+635
New +$247K 0.18% 52

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Mayport LLC's CRL Position: Q1 2022 in Review

Mayport LLC sold out of Charles River Laboratories (CRL) in Q1 2022, closing a stake of 635 shares — an estimated $239K sold.

Mayport LLC first reported a position in CRL in Q4 2021 and held it in 1 quarter. The position peaked at $239K in Q4 2021. 644 funds tracked by Wall St. Rank hold CRL as of Q1 2022.

  • Mayport LLC reported no remaining Charles River Laboratories position as of Q1 2022 after selling out during the quarter.
  • Mayport LLC sold 635 Charles River Laboratories shares in Q1 2022, an estimated $239K.
  • Mayport LLC first reported a position in Charles River Laboratories in Q4 2021 and held it in 1 quarter.
  • Mayport LLC's Charles River Laboratories position peaked at $239K in Q4 2021.
  • 644 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2022.

Based on Mayport LLC's 13F filing for Q1 2022, filed 15 Apr 2022.